Claudio Renjifo Romero in San Juan, Puerto Rico

Home Puerto Rico San Juan

Claudio Renjifo Romero has Endocrinology as his primary medical specialty. Their primary office is: 359 Ave De Diego in San Juan, Puerto Rico. They attended Sorry, his university is not listed and graduated in 1972 (around 52 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Claudio Renjifo Romero Office Phone and Directions

Claudio Renjifo Romero
359 Ave De Diego
San Juan, Puerto Rico 00909
787-724-2491

Patient Ratings
Please rate your experience with Claudio Renjifo Romero below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 787-724-2491

Enter a starting address:

Healthcare Info for Claudio Renjifo Romero

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1972
The Primary Medical Specialty for Claudio Renjifo Romero is listed as: Endocrinology
Approximate Years of Experience: 52
PAC (PECOS ID)#: 3072604537
NPI #: 1679505457
NPI Created On: 07/06/2006
NPI Last Updated Listed as: 07/21/2022
Primary Taxonomy Code: 207RE0101X

URL not found for state: PR licensing board.
License Number:
6454
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Established patient office or other outpatient visit, typically 15 minutes
Physician telephone patient service, 5-10 minutes of medical discussion

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788550505

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $102